VENETIA SMITH: Open Payments
NPI 1124306097 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,812 in 83 payments from 21 companies in 2025. Trend: 2023 $1,919 · 2024 $2,161 · 2025 $1,812
Food & beverage: $1,812
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $624 |
| Lilly USA, LLC | 13 | $220 |
| Novo Nordisk Inc | 8 | $175 |
| Abbott Laboratories | 5 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $108 |
| ABBVIE INC. | 6 | $93 |
| PFIZER INC. | 5 | $82 |
| Seqirus USA Inc | 2 | $63 |
| Phathom Pharmaceuticals, Inc. | 5 | $54 |
| GlaxoSmithKline, LLC. | 2 | $39 |
Products named: BREZTRI, AIRSUPRA, MOUNJARO, FARXIGA, Ozempic, Kerendia, NURTEC ODT, QULIPTA.
Industry payments across TN — which companies pay providers there.
